These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32536957)

  • 21. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
    Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M
    Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RANKL inhibition: a novel strategy to decrease femoral head deformity after ischemic osteonecrosis.
    Kim HK; Morgan-Bagley S; Kostenuik P
    J Bone Miner Res; 2006 Dec; 21(12):1946-54. PubMed ID: 17002576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relationship between coronary and abdominal calcification score, serum osteoprotegerin (OPG), and serum tartrate-resistant acid phosphatase (TRACP) -5b in pre-dialysis CKD patients].
    Shiota J; Izumi N; Kasahara H; Tagawa H; Chiba T; Nihei H
    Nihon Jinzo Gakkai Shi; 2010; 52(8):1022-8. PubMed ID: 21254698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osteoprotegerin expressed by osteoclasts: an autoregulator of osteoclastogenesis.
    Kang JH; Ko HM; Moon JS; Yoo HI; Jung JY; Kim MS; Koh JT; Kim WJ; Kim SH
    J Dent Res; 2014 Nov; 93(11):1116-23. PubMed ID: 25256714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteoprotegerin/RANK/RANKL axis in cardiac remodeling due to immuno-inflammatory myocardial disease.
    Liu W; Feng W; Wang F; Li W; Gao C; Zhou B; Ma M
    Exp Mol Pathol; 2008 Jun; 84(3):213-7. PubMed ID: 18417124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of dietary calcium to available phosphorus ratios on bone metabolism and osteoclast activity of the OPG /RANK/RANKL signalling pathway in piglets.
    Zhao L; Li M; Sun H
    J Anim Physiol Anim Nutr (Berl); 2019 Jul; 103(4):1224-1232. PubMed ID: 31062421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Omentin-1 exerts bone-sparing effect in ovariectomized mice.
    Xie H; Xie PL; Luo XH; Wu XP; Zhou HD; Tang SY; Liao EY
    Osteoporos Int; 2012 Apr; 23(4):1425-36. PubMed ID: 21755404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells.
    Kwan Tat S; Pelletier JP; Lajeunesse D; Fahmi H; Lavigne M; Martel-Pelletier J
    Clin Exp Rheumatol; 2008; 26(2):295-304. PubMed ID: 18565252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the effects of genistein and zoledronic acid on the bone loss in OPG-deficient mice.
    Liu J; Xu K; Wen G; Guo H; Li S; Wu X; Dai R; Sheng Z; Liao E
    Bone; 2008 May; 42(5):950-9. PubMed ID: 18337202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-145 Mediates Steroid-Induced Necrosis of the Femoral Head by Targeting the OPG/RANK/RANKL Signaling Pathway.
    Zhao JJ; Wu ZF; Wang L; Feng DH; Cheng L
    PLoS One; 2016; 11(7):e0159805. PubMed ID: 27459539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Compressive force induces osteoclast differentiation via prostaglandin E(2) production in MC3T3-E1 cells.
    Sanuki R; Shionome C; Kuwabara A; Mitsui N; Koyama Y; Suzuki N; Zhang F; Shimizu N; Maeno M
    Connect Tissue Res; 2010 Apr; 51(2):150-8. PubMed ID: 20001844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Yougui pills exert osteoprotective effects on rabbit steroid-related osteonecrosis of the femoral head by activating β-catenin.
    Zhang P; Xu H; Wang P; Dong R; Xia C; Shi Z; Xu R; Fang L; Zou Z; Ge Q; Tong P; Jin H
    Biomed Pharmacother; 2019 Dec; 120():109520. PubMed ID: 31629251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Genes Variants in RANKL/RANK/OPG Signaling Pathway with the Development of Osteonecrosis of the Femoral Head in Chinese Population.
    Song Y; Du ZW; Yang QW; Ren M; Wang QY; Wang A; Chen GY; Zhao HY; Yu T; Zhang GZ
    Int J Med Sci; 2017; 14(7):690-697. PubMed ID: 28824302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteoclastic activity was associated with the development of steroid-induced osteonecrosis of femoral head.
    He MC; Zhang J; Chen XJ; Shen YS; Fang B; Qin YX; He W; Wei QS
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):1036-1046. PubMed ID: 32667225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of osteoprotegerin in combination with interleukin-6 on inhibition of osteoclast differentiation.
    Wang X; Luo Y; Liao WB; Zhang J; Chen TM
    Chin J Traumatol; 2013; 16(5):277-80. PubMed ID: 24103822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-1 alpha stimulates the formation of osteoclast-like cells by increasing M-CSF and PGE2 production and decreasing OPG production by osteoblasts.
    Tanabe N; Maeno M; Suzuki N; Fujisaki K; Tanaka H; Ogiso B; Ito K
    Life Sci; 2005 Jun; 77(6):615-26. PubMed ID: 15921993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age of donor alters the effect of cyclic hydrostatic pressure on production by human macrophages and osteoblasts of sRANKL, OPG and RANK.
    Evans CE; Mylchreest S; Andrew JG
    BMC Musculoskelet Disord; 2006 Mar; 7():21. PubMed ID: 16519799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ST1926 Attenuates Steroid-Induced Osteoporosis in Rats by Inhibiting Inflammation Response.
    Zhao HX; Huang YX; Tao JG
    J Cell Biochem; 2017 Aug; 118(8):2072-2086. PubMed ID: 27918081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LPS-stimulated human gingival fibroblasts inhibit the differentiation of monocytes into osteoclasts through the production of osteoprotegerin.
    Nagasawa T; Kobayashi H; Kiji M; Aramaki M; Mahanonda R; Kojima T; Murakami Y; Saito M; Morotome Y; Ishikawa I
    Clin Exp Immunol; 2002 Nov; 130(2):338-44. PubMed ID: 12390325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-34 Aggravates Steroid-Induced Osteonecrosis of the Femoral Head via Promoting Osteoclast Differentiation.
    Wang F; Min HS; Shan H; Yin F; Jiang C; Zong Y; Ma X; Lin Y; Zhou Z; Yu X
    Immune Netw; 2022 Jun; 22(3):e25. PubMed ID: 35799706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.